Thanks to Intelicaps, the protection of microorganisms during gastric passage multiplied by 100 to 1000.
An in vitro SHIME study (dynamic scientific model reproducing the digestive system) tested the viability of probiotics (strains of Bifidobacterium lactis and Lactobacillus rhamnosus) during gastric passage. Five reactors reproducing the environmental conditions of the stomach and the small intestine at different stages of passage were analyzed independently. The concentration of bacteria was compared in freeze-dried forms or in Intelicaps® microcapsules….. This concludes with a viability of 100 to 1000 times higher in the case of microcapsules.
Vésale Pharma has already introduced two products with Intelicaps technology on the Belgian market: Bacilac Forte and Bacilac Immunitum
